litlas
ログインアカウント作成

Stefano Romeo

1998–2026 年に発表

136
論文数
20,305
被引用数
73
h 指数
127
i10 指数

被引用数

Stefano Romeo の年別被引用数1972 年: 被引用 1 件1991 年: 被引用 1 件1994 年: 被引用 1 件1995 年: 被引用 3 件1999 年: 被引用 7 件2000 年: 被引用 10 件2001 年: 被引用 18 件2002 年: 被引用 20 件2003 年: 被引用 20 件2004 年: 被引用 34 件2005 年: 被引用 31 件2006 年: 被引用 22 件2007 年: 被引用 32 件2008 年: 被引用 54 件2009 年: 被引用 77 件2010 年: 被引用 109 件2011 年: 被引用 103 件2012 年: 被引用 106 件2013 年: 被引用 161 件2014 年: 被引用 147 件2015 年: 被引用 245 件2016 年: 被引用 248 件2017 年: 被引用 218 件2018 年: 被引用 214 件2019 年: 被引用 730 件2020 年: 被引用 1,118 件2021 年: 被引用 1,149 件2022 年: 被引用 973 件2023 年: 被引用 800 件2024 年: 被引用 1,277 件2025 年: 被引用 803 件2026 年: 被引用 43 件1973〜1990 年は被引用が無いため表示していません1992〜1993 年は被引用が無いため表示していません1996〜1998 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,906 件、この内訳の 19.6%中国: 引用元論文 943 件、この内訳の 9.7%イタリア: 引用元論文 882 件、この内訳の 9.1%イギリス: 引用元論文 699 件、この内訳の 7.2%ドイツ: 引用元論文 491 件、この内訳の 5.1%スウェーデン: 引用元論文 353 件、この内訳の 3.6%日本: 引用元論文 262 件、この内訳の 2.7%スペイン: 引用元論文 256 件、この内訳の 2.6%オーストラリア: 引用元論文 254 件、この内訳の 2.6%フランス: 引用元論文 250 件、この内訳の 2.6%カナダ: 引用元論文 224 件、この内訳の 2.3%オランダ: 引用元論文 200 件、この内訳の 2.1%
0%19.6%その他 30.8%

機関

分野

  • Medicine77.6%
  • Biochemistry, Genetics and Molecular Biology13.9%
  • Neuroscience4%
  • Immunology and Microbiology0.9%
  • Engineering0.5%
  • Nursing0.5%
  • その他2.6%

トピック

  • Liver Disease Diagnosis and Treatment18.9%
  • Diet, Metabolism, and Disease6.8%
  • Diabetes, Cardiovascular Risks, and Lipoproteins4.8%
  • Diet and metabolism studies3%
  • Alcohol Consumption and Health Effects2.9%
  • Lipid metabolism and disorders2.8%
  • その他60.8%

共著者

全論文

検索で開く
  1. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease

    著者: Stefano Romeo, Julia Kozlitina, Chao Xing, Alexander Pertsemlidis, David Cox, L Pennacchio, Eric Boerwinkle, Jonathan C. Cohen, Helen H. Hobbs - Nature Genetics 2008 被引用: 3,385

  2. EU-Wide Cross-Sectional Observational Study of Lipid-Modifying Therapy Use in Secondary and Primary Care: the DA VINCI study

    著者: Kausik K. Ray, Bart Molemans, W. Marieke Schoonen, Periklis Giovas, Sarah Bray, Gaia Kiru, Jennifer Murphy, Maciej Banach, Stefano De Servi, Dan Gaiță, Ioanna Gouni‐Berthold, G. Kees Hovingh, Jacek Jerzy Jozwiak, J. Wouter Jukema, Róbert Gábor Kiss, Serge Kownator, Helle K. Iversen, Vincent Maher, L. Masana, Alexander Parkhomenko, André Peeters, Piers Clifford, Katarı́na Rašlová, Peter Siostrzonek, Stefano Romeo, Dimitrios Tousoulis, Charalambos Vlachopoulos, Michal Vrablı́k, Alberico L. Catapano, Neil R Poulter, the DA VINCI study - European Journal of Preventive Cardiology 2020 被引用: 767

  3. Endocrine aspects of metabolic dysfunction-associated steatotic liver disease (MASLD): Beyond insulin resistance

    著者: Alan L. Hutchison, Federica Tavaglione, Stefano Romeo, Michael Charlton - Journal of Hepatology 2023 被引用: 227

  4. Genetics and epigenetics of NAFLD and NASH: Clinical impact

    著者: Mohammed Eslam, Luca Valenti, Stefano Romeo - Journal of Hepatology 2017 被引用: 991

  5. Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scores

    著者: Cristiana Bianco, Oveis Jamialahmadi, Serena Pelusi, Guido Baselli, Paola Dongiovanni, Irene Zanoni, Luigi Santoro, S. Maier, Antonio Liguori, Marica Meroni, V. Borroni, Roberta D’Ambrosio, Rocco Spagnuolo, Anna Alisi, Alessandro Federico, Elisabetta Bugianesi, Salvatore Petta, Luca Miele, Umberto Vespasiani‐Gentilucci, Quentin M. Anstee, Felix Stickel, Jochen Hampe, Janett Fischer, Thomas Berg, Anna Ludovica Fracanzani, Giorgio Soardo, Helen L. Reeves, Daniele Prati, Stefano Romeo, Luca Valenti - Journal of Hepatology 2020 被引用: 362

  6. An Integrated Understanding of the Rapid Metabolic Benefits of a Carbohydrate-Restricted Diet on Hepatic Steatosis in Humans

    著者: Adil Mardinoğlu, Hao Wu, Elias Björnson, Cheng Zhang, Antti Hakkarainen, Sari Räsänen, Sunjae Lee, Rosellina Margherita Mancina, Mattias Bergentall, Kirsi H. Pietiläinen, Sanni Söderlund, Niina Matikainen, Marcus Ståhlman, Per‐Olof Bergh, Martin Adiels, Brian Piening, Marit Granér, Nina Lundbom, Kevin Jon Williams, Stefano Romeo, Jens Nielsen, M Snyder, Mathias Uhlén, Göran Bergström, Rosie Perkins, Hanns–Ulrich Marschall, Fredrik Bäckhed, Marja‐Riitta Taskinen, Jan Borén - Cell Metabolism 2018 被引用: 477

  7. The first MASH drug therapy on the horizon: Current perspectives of resmetirom

    著者: Salvatore Petta, Giovanni Targher, Stefano Romeo, Utpal B. Pajvani, Ming‐Hua Zheng, Alessio Aghemo, Luca Valenti - Liver International 2024 被引用: 151

  8. Interaction between estrogen receptor-α and PNPLA3 p.I148M variant drives fatty liver disease susceptibility in women

    著者: Alessandro Cherubini, Mahnoosh Ostadreza, Oveis Jamialahmadi, Serena Pelusi, Eniada Rrapaj, Elia Casirati, Giulia Passignani, Marjan Norouziesfahani, Elena Sinopoli, Guido Baselli, Clara Meda, Paola Dongiovanni, Daniele Dondossola, Neil A. Youngson, Aikaterini Tourna, Shilpa Chokshi, Elisabetta Bugianesi, EPIDEMIC Study Investigators, Luisa Ronzoni, Cristiana Bianco, Laura Cerami, Veronica Torcianti, Giulia Periti, Sara Margarita, Rossana Carpani, Francesco Malvestiti, Ilaria Marini, Melissa Tomasi, Angela Lombardi, Jessica Rondena, Marco Maggioni, Roberta D’Ambrosio, Valentina Vaira, Anna Ludovica Fracanzani, Chiara Rosso, Grazia Pennisi, Salvatore Petta, Antonio Liguori, Luca Miele, Federica Tavaglione, Umberto Vespasiani‐Gentilucci, Marcello Dallio, Alessandro Federico, Giorgio Soardo, Jussi Pihlajamäki, Ville Männistö, Sara Della Torre, Daniele Prati, Stefano Romeo, Luca Valenti - Nature Medicine 2023 被引用: 131

  9. The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent

    著者: Rosellina Margherita Mancina, Paola Dongiovanni, Salvatore Petta, Piero Pingitore, Marica Meroni, Raffaela Rametta, Jan Borén, Tiziana Montalcini, Arturo Pujia, Olov Wiklund, George Hindy, Rocco Spagnuolo, Benedetta Maria Motta, Rosaria Maria Pipitone, Antonio Craxı̀, Silvia Fargion, Valério Nobili, Pirjo Käkelä, Vesa Kärjä, Ville Männistö, Jussi Pihlajamäki, Dermot F. Reilly, José Castro‐Perez, Julia Kozlitina, Luca Valenti, Stefano Romeo - Gastroenterology 2016 被引用: 664

  10. Causal relationship of hepatic fat with liver damage and insulin resistance in nonalcoholic fatty liver

    著者: Paola Dongiovanni, Stefan Stender, Alessandro Pietrelli, Rosellina Margherita Mancina, Annalisa Cespiati, Salvatore Petta, Serena Pelusi, Piero Pingitore, Sara Badiali, Marco Maggioni, Ville Männistö, Stefania Grimaudo, Rosaria Maria Pipitone, Jussi Pihlajamäki, Antonio Craxı̀, Magdalena Taube, Lena Carlsson, Silvia Fargion, Stefano Romeo, Julia Kozlitina, Luca Valenti - Journal of Internal Medicine 2017 被引用: 368

  11. Macrophage scavenger receptor 1 mediates lipid-induced inflammation in non-alcoholic fatty liver disease

    著者: Olivier Govaere, Sine Kragh Petersen, Nuria Martínez-López, Jasper Wouters, Matthias Van Haele, Rosellina Margherita Mancina, Oveis Jamialahmadi, Orsolya Bilkei‐Gorzo, Pierre Bel Lassen, Rebecca Darlay, Julien Peltier, Jeremy M. Palmer, Ramy Younes, Dina Tiniakos, Guruprasad P. Aithal, Michael Allison, Michèle Vacca, Melker Göransson, Rolando Berlinguer‐Palmini, James Clark, Michael Drinnan, Hannele Yki‐Järvinen, Jean‐François Dufour, Mattias Ekstedt, Sven Francque, Salvatore Petta, Elisabetta Bugianesi, Jörn M. Schattenberg, Christopher P. Day, Heather J. Cordell, Baki Topal, Karine Clément, Stefano Romeo, Vlad Ratziu, Tania Roskams, Ann K. Daly, Quentin M. Anstee, Matthias Trost, Anetta Härtlová - Journal of Hepatology 2021 被引用: 160

  12. Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease

    著者: Paola Dongiovanni, Salvatore Petta, Cristina Maglio, Anna Ludovica Fracanzani, Rosaria Maria Pipitone, Enrico Mozzi, Benedetta Maria Motta, Dorota Kamińska, Raffaela Rametta, Stefania Grimaudo, Serena Pelusi, Tiziana Montalcini, Anna Alisi, Marco Maggioni, Vesa Kärjä, Jan Borén, Pirjo Käkelä, V. Di Marco, Chao Xing, Valério Nobili, Bruno Dallapiccola, Antonio Craxı̀, Jussi Pihlajamäki, Silvia Fargion, Lars Sjöström, Lena Carlsson, Stefano Romeo, Luca Valenti - Hepatology 2014 被引用: 529

  13. Leveraging Human Genetics to Identify Potential New Treatments for Fatty Liver Disease

    著者: Stefano Romeo, Arun J. Sanyal, Luca Valenti - Cell Metabolism 2020 被引用: 208

  14. A Polygenic Risk Score to Refine Risk Stratification and Prediction for Severe Liver Disease by Clinical Fibrosis Scores

    著者: Antonio De Vincentis, Federica Tavaglione, Oveis Jamialahmadi, Antonio Picardi, Raffaele Antonelli Incalzi, Luca Valenti, Stefano Romeo, Umberto Vespasiani‐Gentilucci - Clinical Gastroenterology and Hepatology 2021 被引用: 144

  15. Partitioned polygenic risk scores identify distinct types of metabolic dysfunction-associated steatotic liver disease

    著者: Oveis Jamialahmadi, Antonio De Vincentis, Federica Tavaglione, Francesco Malvestiti, Ruifang Li‐Gao, Rosellina Margherita Mancina, Marcus Alvarez, Kyla Gelev, Samantha Maurotti, Umberto Vespasiani‐Gentilucci, Frits R. Rosendaal, Julia Kozlitina, Päivi Pajukanta, François Pattou, Luca Valenti, Stefano Romeo - Nature Medicine 2024 被引用: 100

  16. Therapeutic opportunities for the treatment of NASH with genetically validated targets

    著者: Daniel Lindén, Stefano Romeo - Journal of Hepatology 2023 被引用: 84

  17. Statin use and non-alcoholic steatohepatitis in at risk individuals

    著者: Paola Dongiovanni, Salvatore Petta, Ville Männistö, Rosellina Margherita Mancina, Rosaria Maria Pipitone, Vesa Kärjä, Marco Maggioni, Pirjo Käkelä, Olov Wiklund, Enrico Mozzi, Stefania Grimaudo, Dorota Kamińska, Raffaela Rametta, Antonio Craxı̀, Silvia Fargion, Valério Nobili, Stefano Romeo, Jussi Pihlajamäki, Luca Valenti - Journal of Hepatology 2015 被引用: 383

  18. Pnpla3 silencing with antisense oligonucleotides ameliorates nonalcoholic steatohepatitis and fibrosis in Pnpla3 I148M knock-in mice

    著者: Daniel Lindén, Andrea Ahnmark, Piero Pingitore, Ester Ciociola, Ingela Ahlstedt, Anne-Christine Andréasson, Kavitha Sasidharan, Katja Madeyski-Bengtson, Magdalena Zurek, Rosellina Margherita Mancina, Anna Lindblom, Mikael Bjursell, Gerhard Böttcher, Marcus Ståhlman, Mohammad Bohlooly‐Y, William G. Haynes, Björn Carlsson, Mark J. Graham, Richard Lee, Sue Murray, Luca Valenti, Sanjay Bhanot, Peter Åkerblad, Stefano Romeo - Molecular Metabolism 2019 被引用: 210

  19. Data-driven cluster analysis identifies distinct types of metabolic dysfunction-associated steatotic liver disease

    著者: Violeta Raverdy, Federica Tavaglione, Estelle Chatelain, Guillaume Lassailly, Antonio De Vincentis, Umberto Vespasiani‐Gentilucci, S. U. Qadri, Robert Caïazzo, Hélène Verkindt, Chiara Saponaro, Julie Kerr‐Conte, Grégory Baud, Camille Marciniak, Mikaël Chetboun, Naima Oukhouya‐Daoud, Samuel Blanck, Jimmy Vandel, Lisa Olsson, Rima Chakaroun, Viviane Gnemmi, Emmanuelle Leteurtre, Philippe Lefèbvre, Joel T. Haas, Hannele Yki‐Järvinen, Sven Francque, Bart Staels, Carel W. le Roux, Valentina Tremaroli, Philippe Mathurin, Guillemette Marot, Stefano Romeo, François Pattou - Nature Medicine 2024 被引用: 134

  20. Development and Validation of a Score for Fibrotic Nonalcoholic Steatohepatitis

    著者: Federica Tavaglione, Oveis Jamialahmadi, Antonio De Vincentis, S. U. Qadri, Mohammad Erfan Mowlaei, Rosellina Margherita Mancina, Ester Ciociola, Simone Carotti, Giuseppe Perrone, Vincenzo Bruni, Ida Francesca Gallo, Dario Tuccinardi, Cristiana Bianco, Daniele Prati, Silvia Manfrini, Paolo Pozzilli, Antonio Picardi, Marco Caricato, Hannele Yki‐Järvinen, Luca Valenti, Umberto Vespasiani‐Gentilucci, Stefano Romeo - Clinical Gastroenterology and Hepatology 2022 被引用: 110

  21. Exome-Wide Association Study on Alanine Aminotransferase Identifies Sequence Variants in the GPAM and APOE Associated With Fatty Liver Disease

    著者: Oveis Jamialahmadi, Rosellina Margherita Mancina, Ester Ciociola, Federica Tavaglione, Panu K. Luukkonen, Guido Baselli, Francesco Malvestiti, Dorothée Thuillier, Violeta Raverdy, Ville Männistö, Rosaria Maria Pipitone, Grazia Pennisi, Daniele Prati, Rocco Spagnuolo, Salvatore Petta, Jussi Pihlajamäki, François Pattou, Hannele Yki‐Järvinen, Luca Valenti, Stefano Romeo - Gastroenterology 2021 被引用: 142

  22. Rare ATG7 genetic variants predispose patients to severe fatty liver disease

    著者: Guido Baselli, Oveis Jamialahmadi, Serena Pelusi, Ester Ciociola, Francesco Malvestiti, Marco Saracino, Luigi Santoro, Alessandro Cherubini, Paola Dongiovanni, Marco Maggioni, Cristiana Bianco, Federica Tavaglione, Annalisa Cespiati, Rosellina Margherita Mancina, Roberta D’Ambrosio, Valentina Vaira, Salvatore Petta, Luca Miele, Umberto Vespasiani‐Gentilucci, Alessandro Federico, Jussi Pihlajamäki, Elisabetta Bugianesi, Anna Ludovica Fracanzani, Helen L. Reeves, Giorgio Soardo, Daniele Prati, Stefano Romeo, Luca Valenti, V. Borroni, Antonio Liguori, Luisa Ronzoni, Alessandro Cherubini, Luigi Santoro, Melissa Tomasi, Angela Lombardi, Mahnoosh Ostadreza, Elia Casirati, Ilaria Marini, S. Maier, Chiara Rosso, Gianluca Svegliati‐Baroni, Carlo Santaniello, Marcello Dallio - Journal of Hepatology 2022 被引用: 93

  23. PNPLA3 has retinyl-palmitate lipase activity in human hepatic stellate cells

    著者: Carlo Pirazzi, Luca Valenti, Benedetta Maria Motta, Piero Pingitore, Kristina Hedfalk, Rosellina Margherita Mancina, Maria Antonella Burza, Cesare Indiveri, Yvelise Ferro, Tiziana Montalcini, Cristina Maglio, Paola Dongiovanni, Silvia Fargion, Raffaela Rametta, Arturo Pujia, Linda Andersson, Saswati Ghosal, Malin Levin, Olov Wiklund, Michelina Iacovino, Jan Borén, Stefano Romeo - Human Molecular Genetics 2014 被引用: 355

  24. Indole-3-Propionic Acid, a Gut-Derived Tryptophan Metabolite, Associates with Hepatic Fibrosis

    著者: Ratika Sehgal, Mariana Ilha, Maija Vaittinen, Dorota Kamińska, Ville Männistö, Vesa Kärjä, Marjo Tuomainen, Kati Hanhineva, Stefano Romeo, Päivi Pajukanta, Jussi Pihlajamäki, Vanessa D. de Mello - Nutrients 2021 被引用: 69